The OHSU Department of Pathology and Laboratory Medicine offers an ACGME-accredited one-year fellowship program in Hematopathology. The fellowship provides comprehensive training in morphologic, immunologic and molecular genetic areas of hematopathology, and allows for research and/or elective activities. The program provides fellows with a broad experience in the diagnosis of benign and malignant hematologic diseases, with extensive exposure to ancillary diagnostic techniques.

The OHSU Department of Pathology and Laboratory Medicine offers a one-year, ACGME-accredited Hematopathology Fellowship Program. Hematopathology fellows gain experience in a broad spectrum of adult and pediatric hematopathology, including hands-on training in interpretation of advanced ancillary studies including flow cytometry, immunohistochemistry, and cytogenetic/FISH and molecular techniques. Fellows rotate through bone marrow, lymph node/body fluid, and extramural consultation services as well as coagulation and molecular/cytogenetic services. OHSU has an active bone marrow transplant program and is the only academic medical center in Oregon. In addition, the service receives cases from Doernbecher Children's Hospital and consultations from regional laboratories and private groups.  The case mix is varied and interesting, and prepares fellows well for success in academic and non-academic careers.

Perhaps the greatest strength of the program is our people. The program has seven faculty with a range of strengths and backgrounds, faculty with board certification in Molecular/Genetic Pathology, faculty with experience signing out Surgical Pathology, and numerous laboratory medical directors. We foster a collegial attitude and friendly atmosphere, and we value working colleagues, teammates, and trainees who share these goals.

Fellows have direct responsibility for evaluating and reporting of bone marrow biopsies, lymph node/surgical specimens, peripheral blood and body fluid specimens, and consultation cases. Fellows gain broad experience in diagnosing neoplastic and non-neoplastic hematologic disorders, with a caseload of approximately 1,700 bone marrow biopsies and 400 lymph node/tissue biopsies per year. With supervision, fellows are expected to prepare reports, order appropriate immunohistochemical and ancillary testing, and interpret the results of testing. Fellows gain extensive exposure in advanced hematopathology techniques, including flow cytometry gating strategies for minimal residual disease evaluation and interpretation of targeted next-generation sequencing studies in addition to routine morphologic and immunohistochemical evaluation. Fellows are also encouraged to participate in ongoing Hematopathology Section clinical research activities.

The clinical and teaching responsibilities of fellows include regularly scheduled instructional conferences for pathology residents and informal and formal consultation with residents and faculty within and outside of the Pathology department. Fellows will have ample opportunities to learn and practice hematopathology and laboratory hematology within a clinical context. Fellows have increasing levels of responsibility commensurate with level of performance.

Mission Statement and Program Aims

The mission of the OHSU hematopathology fellowship program is to train excellent diagnosticians who are experts in Hematopathology, including all relevant ancillary techniques, and who are well-prepared for successful academic or non-academic careers.

The primary goal of the Hematopathology Fellowship Program is to train fellows to be qualified hematopathologists who can practice competently and independently in any clinical setting and to provide a supportive educational environment where fellows will achieve the following competency-specific goals.

Eligibility

Applicants must have completed 3 years of AP or CP training or 4 years of AP/CP training in an ACGME- or RCPSC-accredited program and have passed the USMLE Step 3 exam. Applicants must be legally able to work in the U.S., or eligible to obtain work authorization, and are expected to take and pass the ABP hematology examination upon graduation.

Our hematopathology fellowship program is participating in the National Residency Matching Program (NRMP) for 2026-27 endorsed by the Society for Hematopathology. Find more information about the process here